PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer

NCT02423603 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: AZD5363
DRUG: Placebo

Sponsor

Queen Mary University of London

Collaborators

[object Object]
[object Object]